Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays

Cancer Research

Volumn 65, Issue 6, 2005, Pages 2115-2124

  Nishigaki, Michiko ^a   Aoyagi, Kazuhiko ^a   Danjoh, Inaho ^a   Fukaya, Masahide ^a   Yanagihara, Kazuyoshi ^a   Sakamoto, Hiromi ^a   Yoshida, Teruhiko ^a   Sasaki, Hiroki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; RAS PROTEIN; RHO FACTOR; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1; TRICHOSTATIN A;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CELL ADHESION; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DNA MICROARRAY; GENE IDENTIFICATION; GENE SILENCING; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; INTRON; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH MUCOSA; UNINDEXED SEQUENCE;

AZACITIDINE; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GTP PHOSPHOHYDROLASES; HUMANS; HYDROXAMIC ACIDS; INTRONS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RAS PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANS-ACTIVATION (GENETICS);

EID: 16844384464     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3340     Document Type: Article

References (42)

1. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
2. Costello JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-8.
3. Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003;3:89-95.
4. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53.
5. Jaenisch R, Schnieke A, Harbers K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc Natl Acad Sci U S A 1985;82:1451-5.
6. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998;395:89-93.
7. Gaudet F, Hodgson JG, Eden A, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-92.
8. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their counterpart. Nature 1983;301:89-91.
9. Cho M, Uemura H, Kim S, et al. Hypomethylation of the MN/CA9 promoter and up-regulated MN/CA9 expression in human renal cell carcinoma. Br J Cancer 2001;85:563-7.
10. Nakayama M, Wada M, Harada T, et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood 1998;92:4296-307.
11. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed J. BCL-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood 1993;82:1820-8.
12. De Smet C, De Backer O, Faraoni I, Lurquin C, Brassuer F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A 1996; 93:7149-53.
13. Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the synuclein γ gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 2003;63:664-73.
14. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:11282-6.
15. Jakes R, Sillantini M, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994;345:27-34.
16. Sato N, Maitra A, Fukushima N, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003;63:4158-66.
17. Fang JY, Xiao SD. Alteration of DNA methylation in gastrointestinal carcinogenesis. J Gastroenterol Hepatol 2001;16:960-8.
18. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95:14863-8.
19. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26:16-7.
20. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes up-regulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002;31:141-9.
21. Song S-H, Jong H-S, Choi H-H, et al. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma. Int J Cancer 2000; 87:236-40.
22. Shin JY, Kim H-S, Park J, Park J-B, Lee JY. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res 2000;60:262-5.
23. Li Q-L, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-24.
24. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 2003;94:360-4.
25. Li J, Yang Y, Fujie T, et al. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin Cancer Res 1996;2:1619-25.
26. Ogasawara S, Maesawa C, Yamamoto M, et al. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers. Oncogene 2004;23: 1117-24.
27. Lowe DG, Capon DJ, Delwart E, Sakaguchi A, Naylor SL, Goeddel DV. Structure of the human and murine R-ras genes, novel genes closely related to ras protooncogenes. Cell 1987;48:137-46.
28. Karam SM, Leblond CP. Origin and migratory pathways of the eleven epithelial cell types present in the body of the mouse stomach. Microsc Res Tech 1995;31:193-214.
29. Aoyagi K, Tatsuta T, Nishigaki M, et al. A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. Biochem Biophys Res Commun 2003;300:915-20.
30. De Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 1995;109:723-34.
31. Ho SB, Roberton AM, Shekels LL, Lyftogt CT, Niehans GA, Toribara NW. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 1995;109:735-47.
32. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002;12: 996-1006.
33. Karolchik D, Baertsch R, Diekhans M, et al. The UCSC Genome Browser Database. Nucleic Acids Res 2003;31:51-4.
34. Saez R, Chan AM, Mild T, Aaronson SA. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes. Oncogene 1994;9:2977-82.
35. Takahashi K, Mitsui K, Yamanaka S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 2003;423:541-5.
36. Fernandez-Sarabia MJ, Bishoff JR. Bcl-2 associates with the ras-related protein R-ras p23. Nature 1993;366:274-5.
37. Troppmair J, Rapp UR. Apoptosis regulation by Raf, Bcl-2, and R-RAS. Recent Results Cancer Res 1997;143:245-9.
38. McCormick F. Ras-related proteins in signal transduction and growth control. Mol Reprod Dev 1995;42:500-6.
39. Hansen M, Rusyn EV, Hughes PE, Ginsberg MH, Cox AD, Willumsen BM. R-Ras C-terminal sequences are sufficient to confer R-Ras specificity to H-Ras. Oncogene 2002;21:4448-61.
40. Zhang Z, Vuori K, Wang H-G, Reed JC, Ruoslahti E. Integrin activation by R-RAS. Cell 1996;85:61-9.
41. Kwong L, Wozniak MA, Collins AS, Wilson SD, Keely PJ. R-RAS promotes focal adhesion formation through focal adhesion kinase and 130 (Cas) by a novel mechanism that differs from integrins. Mol Cell Biol 2003;23:933-49.
42. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002;99:3740-5.